MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Eat in 8 hours, fight fatty liver: new diet trial launches
Disease control Not yet recruitingThis study tests whether eating all meals within an 8-hour window each day (time-restricted eating) can help people with fatty liver disease (MASLD) lose weight and reduce liver fat. 150 adults will follow either this eating pattern or standard care for 3 months. Researchers will…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Cyprus University of Technology • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Time-Restricted eating: a new weapon against fatty liver?
Disease control Not yet recruitingThis study tests whether limiting food intake to an 8-hour daytime window (and fasting for 16 hours) can reduce liver fat in people with obesity and a type of fatty liver disease called MASLD. Researchers will enroll 72 adults and measure liver fat using MRI before and after 12 w…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
Shocking diabetes treatment? new procedure aims to reset the gut
Disease control Not yet recruitingThis study tests a procedure called ReCET that uses mild electrical pulses to treat the lining of the small intestine. It aims to improve blood sugar control and reduce fat in the liver for people with type 2 diabetes and fatty liver disease who haven't had success with standard …
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
AI spots silent liver disease during heart checkups
Diagnosis Not yet recruitingThis study tests whether artificial intelligence (AI) can spot early signs of liver disease (MASLD or cirrhosis) in people getting a routine heart ultrasound. About 2,000 adults flagged as high-risk by the AI will be followed to see if they get diagnosed and treated faster than u…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Kaiser Permanente • Aim: Diagnosis
Last updated May 26, 2026 03:27 UTC
-
Hidden liver risks in type 1 diabetes: new study aims to find out
Knowledge-focused Not yet recruitingThis study will check how common fatty liver disease and liver scarring are in adults with type 1 diabetes or LADA in Quebec. About 100 participants will have a single visit for a liver scan and other tests. The goal is to find undiagnosed liver problems and see if body weight pl…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Institut de Recherches Cliniques de Montreal • Aim: Knowledge-focused
Last updated May 26, 2026 03:24 UTC
-
Gut germs linked to liver damage in new study
Knowledge-focused Not yet recruitingThis study looks at whether gut bacteria in people with fatty liver disease (MASLD) produce certain chemicals that may harm the liver. Researchers will collect stool samples from 24 participants (patients and healthy volunteers) and grow the bacteria in the lab to measure these c…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 26, 2026 03:11 UTC
-
Computer coach for doctors aims to improve fatty liver care
Knowledge-focused Not yet recruitingThis study tests whether an electronic decision-support system can help primary care doctors, endocrinologists, and gastroenterologists better manage patients with metabolic-dysfunction associated steatotic liver disease (MASLD). About 7,200 adults will take part. The goal is to …
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC
-
Exercise may help fight fatty liver in seniors, new study suggests
Knowledge-focused Not yet recruitingThis study looks at whether a 12-week exercise program can reduce liver fat, inflammation, and scarring in people with metabolic fatty liver disease. It compares results between older adults (70+) and middle-aged adults (40-60), as well as between those with mild and more advance…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER) • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC